← Leaderboards
Konstantin Christov-Tzelkov
University Of Illinois At Chicago
$312,870
Attributed
$312,870
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $78.5K · FY2009–10$100K$75K$50K$25K$0
'09
'10
Funding mix
By agency
NIH$312,870 · 3
By mechanism
R03$312,870 · 2
N01$0 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Illinois At Chicago
Same institution · by research overlap
- Ah-Ng Tony Kong$19,827,201
- Rajendra G Mehta$5,791,028
- Hiroaki Kiyokawa$7,592,989
- Alan Diamond$5,594,746
- Dale B Hales$3,074,667
Others in their field
Top investigators on “Cell Proliferation”
- John M Lachin · George Washington University$118,921,924
- David M Nathan · Massachusetts Institute Of Technology$118,921,924
- David Heimbrook · Leidos Biomedical Research, Inc.$103,164,048
- Timothy J Eberlein · Washington University$49,931,668
- Deirdre R. Meldrum · University Of Washington$37,202,510
- Robert A Weinberg · Whitehead Institute For Biomedical Res$32,735,166
Research focus
Cell ProliferationMammary GlandBiomarkerChemical CarcinogenesisApoptosisBreast NeoplasmsAntitumor AgentAnimal ModelClinical TrialsCellsCancer Cell LineCancer PreventionCancer TypeBreastBreast CarcinomaApplications GrantsBreast Cancer TreatmentCell AgingCell Cycle ArrestCell Cycle ProteinsBreast Cancer PreventionCdkn2a GeneCarcinomaAnimals
Grant awards (5)
Role of cellular senescence in mammary cancer prevention by Rexinoids.$78,500
R03 · FY2010 · CA · contact PI
Role of cellular senescence in mammary cancer prevention by Rexinoids.$78,500
R03 · FY2009 · CA · contact PI
P27Kipl deficiency, potential promoter of carcinogenesis$77,935
R03 · FY2003 · CA
P27Kipl deficiency, potential promoter of carcinogenesis$77,935
R03 · FY2002 · CA
MULTIPLE BIOMARKER ENDPOINTS IN MAMMARY TUMOR MODEL$0
N01 · FY2001 · CN